2004
DOI: 10.1097/01.ju.0000116410.13874.b8
|View full text |Cite
|
Sign up to set email alerts
|

Systematic in Vitro Evaluation of Survivin Directed Antisense Oligodeoxynucleotides in Bladder Cancer Cells

Abstract: The survivin directed AS-ODNs shown to inhibit effectively the proliferation of BCa cells in the current study may provide suitable adjuvant therapeutic agents for the specific local treatment of BCa.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
23
0

Year Published

2005
2005
2019
2019

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(24 citation statements)
references
References 16 publications
1
23
0
Order By: Relevance
“…As survivin is known to preferentially bind to and inhibit effector caspases, such as caspase-3 and caspase-7 (Tamm et al, 1998), its reduction by ASODNs in TT cells may potentially contribute to the cell apoptosis. In addition, overt inhibitory effects on cell growth and notable induction of apoptosis by ASODNs have also been found in other tumor cell lines (Xia et al, 2002;Cao et al, 2004;Fuessel et al, 2004;. Thus, the survivin-targeted gene therapy using ASODNs may be one of potentially promising alternatives for treatment of tumors.…”
Section: Discussionmentioning
confidence: 99%
“…As survivin is known to preferentially bind to and inhibit effector caspases, such as caspase-3 and caspase-7 (Tamm et al, 1998), its reduction by ASODNs in TT cells may potentially contribute to the cell apoptosis. In addition, overt inhibitory effects on cell growth and notable induction of apoptosis by ASODNs have also been found in other tumor cell lines (Xia et al, 2002;Cao et al, 2004;Fuessel et al, 2004;. Thus, the survivin-targeted gene therapy using ASODNs may be one of potentially promising alternatives for treatment of tumors.…”
Section: Discussionmentioning
confidence: 99%
“…These strategies comprise antisense oligonucleotides, ribozymes, siRNA, and dominant-negative mutation (35)(36)(37). Promising results have already been reported for survivin targeting in bladder cancer cell lines (38)(39)(40).…”
Section: Deregulated Expression Of Apoptosis Inhibitors Have Beenmentioning
confidence: 96%
“…Promising results have already been reported for survivin targeting in bladder cancer cell lines. 32,33 …”
Section: Discussionmentioning
confidence: 99%